Shanghai Clinical Research Center (SCRC) operates as a 3rd-party full-service assessment and resource center to facilitate drug development. SCRC is developing a core resource platform with coverage of clinical research sites throughout China. A fully equipped central laboratory with GLP capabilities, a state-of-the-art data management and a bio-statistics system position SCRC as a leader in drug development services in China.
Founded under the collaborative framework of the Ministry of Science and Technology and the Shanghai Municipality in 2008, SCRC endeavors to be a pioneer in the globalization of drug development in China by provision of the link necessary between pharmaceutical companies and hospitals. With superior technical skills, abundant public resources, necessary infrastructure and a network providing access to large patient populations, SCRC is dedicated to meeting the challenging needs for clinical expertise, quality services and technological innovation in global drug development.
Bearing the commitment to be the practitioner of the national innovation strategy, SCRC also hosts a Bio-bank and a Translational Medical Research Center, which will leverage the research power by bridging the clinical practice and the fundamental research.